The Neuron or Nerve Cell | Structure and Function of Neuron and Glial cells | Synapse | Neurology https://lnkd.in/d3jA9DpY
NOOR ZAINAB’s Post
More Relevant Posts
-
Neuroscience MSc 🧠 | Healthcare & Project Management Experience with a Global Perspective 🌍
📢 Excited to share our latest EMJ Neurology journal! 🧠 Here, you'll discover the latest updates in the field of neurology. You'll also find a detailed review of the 10th European Academy of Neurology (EAN) Annual Congress, and exclusive interviews with experts in neurology! 🧠 *this content is intended solely for healthcare professionals. #EMJreviews #neurology #congress #MedicalEducation
-
In the latest podcast for The Lancet Neurology, I interviewed Suvankar Pal from the University of Edinburgh about the MND-SMART trial. This innovative platform trial is testing multiple drugs that are already approved for other indications to see if they might also work in people with motor neuron disease. The design means results are available much faster than if a single trial was done, which is so important for people with this devastating disease. #mnd #neurology #podcast https://lnkd.in/ept8pFP7
Suvankar Pal on the motor neuron disease trial MND-SMART - The Lancet Neurology in conversation with
buzzsprout.com
-
Another exciting publication from ANMSA!!! 🧠 Optimized Intracranial Spectroscopic Probe for TBI Monitoring by Clarissa Stickland et al. 📍 Published in Experimental Neurology Focus: Discover how the Intra-RSP probe leverages Raman spectroscopy for real-time monitoring of traumatic brain injuries, offering personalized treatment insights and improving neurological care! 🔗https://lnkd.in/ep_GDwY7
-
Givinostat (EPIDYS) is an ‘HDAC inhibitor’ in that it blocks enzymes called histone deacetylases (HDACs), which are involved in turning genes ‘on’ and ‘off’ within cells and can reduce muscle regeneration in Duchenne. By inhibiting HDAC activity Givinostat (EPIDYS) may help to activate muscle repair mechanisms to increase muscle fiber regeneration, reduce inflammation, and reduce fibrosis. #DuchennemuscularDystrophy #Ikrispharmanetwork Italfarmaco
Italfarmaco Publishes in The Lancet Neurology results from Phase 3 EPIDYS Study in Duchenne Muscular Dystrophy (DMD) #Duchenne, #DMD, #Italfarmaco, #Rarediseases
-
-
Looking to join a network of clinical professionals to help advance the science, practice, and awareness of functional neurology? Join the NeuroNetwork to provide a "closed-loop" model for patients. Learn more at https://goo.gl/91Urfq #PlasticityBrainCenters #FunctionalNeurology #Neuroplasticity #NeuroNetwork #ClosedLoopModel
-
-
Predicting neurologic recovery from disorders of consciousness caused by severe, acute brain injury is one of the main challenges in clinical practice. Neuroprognostication is an increasingly developing field, and new perspectives might help us in delivering the most appropriate care for the patients and the most accurate communication with their families. #neurology #neurointensivecare
Most viewed in the last 7 days from JAMA Neurology: Neuroprognostic markers are rapidly evolving as new ways of assessing the brain’s structural and functional integrity after brain injury are discovered. https://ja.ma/3wUwzIH
-
-
IICN Neurology Update Meeting - Updates in peripheral nerve vasculitis @IICN_ie #vasculitis https://lnkd.in/ek5z9ktV
-
📢 Missed out on a DCR lecture this year? No worries! We are uploading recordings of the lectures to our YouTube channel for you to watch at your convenience. 📺 Now available: ‘Digital Neurology – From Assessments to Interventions’ by Prof. Dr. Tobias Nef 🧠 Shortly, we will be uploading other DCR Lectures. 🎬 Check them out here: https://lnkd.in/g_VR68yz #DCRLecture #DCR #ClinicalResearch #DigitalNeurology
-
